Skip to main content
Fig. 4 | Retrovirology

Fig. 4

From: Janus kinase inhibition suppresses PKC-induced cytokine release without affecting HIV-1 latency reversal ex vivo

Fig. 4

Ruxolitinib significantly decreases ingenol-induced cytokine release. Bars represent the median change in pro-inflammatory cytokine concentrations in PBMC cultures exposed to ruxolitinib + ingenol-3,20-dibenzoate (ingenol DB) compared to ingenol DB alone. PBMCs from aviremic ART-treated individuals (n = 7) were cultured for 72 h. One standard deviation shown by error bars. *P value <0.05; **P value <0.01

Back to article page